|
1
|
Folkman J: Angiogenesis: an organizing
principle for drug discovery? Nat Rev Drug Discov. 6:273–286. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carmeliet P and Jain RK: Principles and
mechanisms of vessel normalization for cancer and other angiogenic
diseases. Nat Rev Drug Discov. 10:417–427. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brown DM and Regillo CD: Anti-VEGF agents
in the treatment of neovascular age-related macular degeneration:
applying clinical trial results to the treatment of everyday
patients. Am J Ophthalmol. 144:627–637. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cook KM and Figg WD: Angiogenesis
inhibitors: current strategies and future prospects. CA Cancer J
Clin. 60:222–243. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ng EW, Shima DT, Calias P, Cunningham ET
Jr, Guyer DR and Adamis AP: Pegaptanib, a targeted anti-VEGF
aptamer for ocular vascular disease. Nat Rev Drug Discov.
5:123–132. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jain RK, Duda DG, Clark JW and Loeffler
JS: Lessons from phase III clinical trials on anti-VEGF therapy for
cancer. Nat Clin Prac Oncol. 3:24–40. 2006. View Article : Google Scholar
|
|
7
|
Kang BK, Lee EH and Kim HM: Inhibitory
effects of Korean folk medicine ‘Hi-Chum’ on histamine release from
mast cells in vivo and in vitro. J Ethnopharmacol. 57:73–79. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim JY, Lim HJ and Ryu JH: In vitro
anti-inflammatory activity of 3-O-methyl-flavones isolated from
Siegesbeckia glabrescens. Bioorg Med Chem Lett. 18:1511–1514. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim HM, Lee JH, Won JH, et al: Inhibitory
effect on immunoglobulin E production in vivo and in vitro by
Siegesbeckia glabrescens. Phytother Res. 15:572–576. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jun SY, Choi YH and Shin HM: Siegesbeckia
glabrescens induces apoptosis with different pathways in human
MCF-7 and MDA-MB-231 breast carcinoma cells. Oncol Rep.
15:1461–1467. 2006.PubMed/NCBI
|
|
11
|
Cho YR, Choi S and Seo DW: The in vitro
antitumor activity of Siegesbeckia glabrescens against ovarian
cancer through suppression of receptor tyrosine kinase expression
and the signaling pathways. Oncol Rep. 30:221–226. 2013.PubMed/NCBI
|
|
12
|
Lee HN, Joo JH, Oh JS, Choi SW and Seo DW:
Regulatory effects of Siegesbeckia glabrescens on non-small cell
lung cancer cell proliferation and invasion. Am J Chin Med.
42:453–463. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hwang JH and Kim JD: Inhibitory effects of
Siegesbeckiae herba extract on angiogenesis and adipogenesis.
Biotechnol Bioprocess Eng. 16:144–152. 2011. View Article : Google Scholar
|
|
14
|
Kim HJ, Cho YR, Kim SH and Seo DW:
TIMP-2-derived 18-mer peptide inhibits endothelial cell
proliferation and migration through cAMP/PKA-dependent mechanism.
Cancer Lett. 343:210–216. 2014. View Article : Google Scholar
|
|
15
|
Lee HN, Kim JK, Kim JH, et al: A
mechanistic study on the anti-cancer activity of ethyl caffeate in
human ovarian cancer SKOV-3 cells. Chem Biol Interact. 219:151–158.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Seo DW, Kim SH, Eom SH, et al: TIMP-2
disrupts FGF-2-induced downstream signaling pathways. Microvasc
Res. 76:145–151. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Seo DW, Li H, Qu CK, et al: Shp-1 mediates
the antiproliferative activity of tissue inhibitor of
metalloproteinase-2 in human microvascular endothelial cells. J
Biol Chem. 281:3711–3721. 2006. View Article : Google Scholar :
|
|
18
|
Kim SH, Cho YR, Kim MD, Kim HJ, Choi SW
and Seo DW: Inhibitory effects of sepiapterin on vascular
endothelial growth factor-A-induced proliferation and adhesion in
human umbilical vein endothelial cells. Arch Pharm Res.
34:1571–1577. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yoon HJ, Cho YR, Joo JH and Seo DW:
Knockdown of integrin α3β1 expression induces proliferation and
migration of non-small cell lung cancer cells. Oncol Rep.
29:662–668. 2013.
|
|
20
|
Bourboulia D and Stetler-Stevenson WG:
Matrix metalloproteinases (MMPs) and tissue inhibitors of
metalloproteinases (TIMPs): positive and negative regulators in
tumor cell adhesion. Semin Cancer Biol. 20:161–168. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Christofori G: New signals from the
invasive front. Nature. 441:444–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lemmon MA and Schlessinger J: Cell
signaling by receptor tyrosine kinases. Cell. 141:1117–1134. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li H, Kim JY, Hyeon J, Lee HJ and Ryu JH:
In vitro antiinflammatory activity of a new sesquiterpene lactone
isolated from Siegesbeckia glabrescens. Phytother Res.
25:1323–1327. 2011.PubMed/NCBI
|
|
24
|
Olsson AK, Dimberg A, Kreuger J and
Claesson-Welsh L: VEGF receptor signalling - in control of vascular
function. Nat Rev Mol Cell Biol. 7:359–371. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ellis LM and Hicklin DJ: VEGF-targeted
therapy: mechanisms of anti-tumour activity. Nat Rev Cancer.
8:579–591. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim SH, Cho YR, Kim HJ, et al: Antagonism
of VEGF-A-induced increase in vascular permeability by an integrin
α3β1-Shp-1-cAMP/PKA pathway. Blood. 120:4892–4902. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Stetler-Stevenson WG: Matrix
metalloproteinases in angiogenesis: a moving target for therapeutic
intervention. J Clin Invest. 103:1237–1241. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Stetler-Stevenson WG: Tissue inhibitors of
metalloproteinases in cell signaling: metalloproteinase-independent
biological activities. Sci Signal. 1:re62008.PubMed/NCBI
|
|
30
|
Brew K and Nagase H: The tissue inhibitors
of metalloproteinases (TIMPs): an ancient family with structural
and functional diversity. Biochim Biophys Acta. 1803:55–71. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Seo DW, Li H, Guedez L, et al: TIMP-2
mediated inhibition of angiogenesis: an MMP-independent mechanism.
Cell. 114:171–180. 2003. View Article : Google Scholar : PubMed/NCBI
|
